UPDATE 1-Swiss drugmaker Actelion upgrades full-year forecast despite profit miss

* H1 operating income 344 mln Sfr vs Rtrs poll avg 366 mln Sfr
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.